Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
Australia
Consano Bio Research Site, Broadmeadow, New South Wales Consano Bio Research Site, Wahroonga, New South Wales Consano Bio Research Site, Melbourne, Victoria